Jenburkt Pharmaceuticals informs about unaudited financial results

28 Oct 2025 Evaluate
Jenburkt Pharmaceuticals has informed that it enclosed Standalone Unaudited financial results for the quarter and half year ended on 30th September, 2025.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1093.20 -12.50 (-1.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×